Mhp493 (P216) is a proteolytically processed, cilium and heparin binding protein of Mycoplasma hyopneumoniae

Jody Wilton1, Cheryl Jenkins, Stuart J Cordwell

  • 1NSW Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Camden, NSW 2570, Australia.

Molecular Microbiology
|December 2, 2008
PubMed

Insights

Mycoplasma hyopneumoniae uses Mhp493 to adhere to swine cilia, causing respiratory disease. This protein fragment, P85, binds heparin and is recognized by antibodies during infection, offering potential therapeutic targets.

Area of Science:

  • Microbiology
  • Veterinary Science
  • Molecular Biology

Background:

  • Mycoplasma hyopneumoniae causes swine respiratory disease by damaging cilia.
  • Heparin binding to M. hyopneumoniae inhibits its adherence to cilia.

Purpose of the Study:

  • Investigate the role of Mhp493 (P216) in M. hyopneumoniae adherence to swine cilia.
  • Characterize the heparin-binding properties and potential immunogenicity of Mhp493 fragments.

Main Methods:

  • Protein cleavage analysis and identification of heparin-binding domains.
  • Mass spectrometry (MALDI-MS/MS) for phosphoserine residue identification.
  • Binding assays using recombinant proteins and cell monolayers.

Main Results:

  • Mhp493 is cleaved into P120 and P85, which bind heparin.
  • A phosphoserine residue at position 94 in P85 is identified.
  • Mhp493 fragments bind porcine cilia and are recognized by infection-elicited antibodies.

Conclusions:

  • Mhp493 is a novel cilium adhesin contributing to M. hyopneumoniae surface architecture.
  • Mhp493 fragments P120 and P85 are key for heparin binding and cilia interaction.
  • This protein represents a potential target for controlling swine respiratory disease.